Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Marie

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Cancer|August 21, 2014
Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastomaJaime Gállego Pérez-Larraya, Sophie Paris, Ahmed Idbaih, et al.
Journal of Neuro-Oncology|July 12, 2008
Genomic changes in progression of low-grade gliomasAhmed Idbaih, Rosana Carvalho Silva, Emmanuelle Crinière, et al.
Neuro-Oncology|February 20, 2009
Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomasSibille Everhard, Jörg Tost, Hafida El Abdalaoui, et al.
Molecular Cancer|May 22, 2008
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profileFrançois Ducray, Ahmed Idbaih, Aurélien de Reyniès, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2011
Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomasFrançois Ducray, Karima Mokhtari, Emmanuelle Crinière, et al.
Cancer Genetics and Cytogenetics|July 28, 2007
Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomasAhmed Idbaih, Blandine Boisselier, Marc Sanson, et al.
Acta Neuropathologica|February 21, 2018
Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk lociKarim Labreche, Ben Kinnersley, Giulia Berzero, et al.
Oncotarget|June 28, 2014
Mutational analysis of primary central nervous system lymphomaAurélie Bruno, Blandine Boisselier, Karim Labreche, et al.
Plos One|September 19, 2014
DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomideAmandine Etcheverry, Marc Aubry, Ahmed Idbaih, et al.
Scientific Reports|May 14, 2021
Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivorsRobert Terziev, Dimitri Psimaras, Yannick Marie, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Cancer|August 21, 2014
Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastomaJaime Gállego Pérez-Larraya, Sophie Paris, Ahmed Idbaih, et al.
Journal of Neuro-Oncology|July 12, 2008
Genomic changes in progression of low-grade gliomasAhmed Idbaih, Rosana Carvalho Silva, Emmanuelle Crinière, et al.
Neuro-Oncology|February 20, 2009
Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomasSibille Everhard, Jörg Tost, Hafida El Abdalaoui, et al.
Molecular Cancer|May 22, 2008
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profileFrançois Ducray, Ahmed Idbaih, Aurélien de Reyniès, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2011
Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomasFrançois Ducray, Karima Mokhtari, Emmanuelle Crinière, et al.
Cancer Genetics and Cytogenetics|July 28, 2007
Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomasAhmed Idbaih, Blandine Boisselier, Marc Sanson, et al.
Acta Neuropathologica|February 21, 2018
Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk lociKarim Labreche, Ben Kinnersley, Giulia Berzero, et al.
Oncotarget|June 28, 2014
Mutational analysis of primary central nervous system lymphomaAurélie Bruno, Blandine Boisselier, Karim Labreche, et al.
Plos One|September 19, 2014
DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomideAmandine Etcheverry, Marc Aubry, Ahmed Idbaih, et al.
Scientific Reports|May 14, 2021
Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivorsRobert Terziev, Dimitri Psimaras, Yannick Marie, et al.
Pageof 11